NCT02728921View on ClinicalTrials.gov

The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Pancreatic NeoplasmsUrogenital NeoplasmSystemic Inflammatory Response SyndromeHypovolemia
Interventions
DRUG

5% Albumin infusion 30 min

Intravenous infusion of 5% Albumin at a dose of 10 ml/kg during 30 minutes. Dose is based on ideal weight.

DRUG

5% Albumin infusion 3 hours

Intravenous infusion of 5% Albumin at a dose of 10 ml/kg during 3 hours. Dose is based on ideal weight.

Trial Locations (1)

Unknown

Skåne University Hospital, Region Skåne, Lund

All Listed Sponsors
lead

Region Skane

OTHER

NCT02728921 - The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery | Biotech Hunter | Biotech Hunter